Discover best practices to investigate novel blood cancer therapies with hematology experts Christopher Morley and Sari Heitner Enschede, MD. This insightful white paper explores how biotech companies can address the challenges around investigational agents for hematologic cancers, while considering patient diversity. https://bit.ly/3XgpIUe #Oncology #Hematology #Biotech #ClinicalTrials #Diversity
IQVIA Biotech
Biotechnology Research
Durham, NC 121,366 followers
Supporting biotech companies from innovation to patient impact
About us
IQVIA Biotech is a biotech-specialized CRO delivering flexible clinical development solutions for biotech and emerging biopharma companies. Our clinical solutions are built on 25 years of unmatched experience with therapeutically aligned expertise, uniquely designed to deliver full-service solutions on a global scale.
- Website
-
https://iqviabiotech.com
External link for IQVIA Biotech
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Durham, NC
- Founded
- 1998
Updates
-
If you missed our webinar with IQVIA Biotech’s Meg Hooton, IQVIA Institute's Murray Aitken and IQVIA's Keith McDonald, it’s not too late! With IQVIA Biotech on-demand, you can catch up on key discussions covering regulatory and strategic drug development, novel trial design, and the rise of AI in clinical research. Ready to unlock complete biotech success? Watch now. https://lnkd.in/dS9M7HHA #Biotech #ClinicalResearch #MedicalResearch
-
With instant access to world-class data and analytics, IQVIA Biotech can help you drive decisions throughout the entire drug development process. Discover our unique approach to serving biotech customers through flexible clinical development solutions. Learn more. https://bit.ly/3CZtevy #ClinicalDevelopment #TherapeuticExpertise
-
-
Rare diseases present complex challenges. IQVIA Biotech simplifies the development of rare disease treatments to help you get treatments to patients. Deliver complex trials on time and chart a smarter path to market. https://bit.ly/4ibuquS #Biotech #RareDisease
-
-
Maria Iñiguez shares her story about how IQVIA Biotech supports both personal and professional goals. “I am honored to be part of the IQVIA family. Amid the challenges of the pandemic when returning to the office seemed daunting; I embraced the opportunity to join this incredible team. The home-based model not only offered flexibility for prioritizing my health but also allowed a seamless balance between my professional and personal life. I am grateful to IQVIA Biotech for not just providing a supportive environment but also a space where professional growth prospers.” Join IQVIA Biotech and make a difference with us! https://bit.ly/41qsfOu #Biotech #CareerGrowth #Support #WorkLifeBalance #WeAreIQVIA #MakingaDifference #GlobalRelationships
-
-
Long-term follow-up (LTFU) studies are an important component of gene therapies, but they present unique challenges for biotech and emerging biopharma. A tailored, patient-centric approach can provide the solution. Download the IQVIA Biotech Insight Brief to learn more. https://bit.ly/3X89RY1 #CAGT #GeneTherapy #Biotech
-
-
Cardiovascular, Renal and Metabolic (CVRM) health represents the fastest expanding disease spectrum globally, linking cardiovascular diseases with related comorbidities, such as obesity, diabetes and chronic kidney disease. IQVIA Biotech’s dedicated CVRM team understands the unique considerations of planning and executing clinical trials across these three areas – allowing you to deliver the best outcomes and maximize patient impact. Learn more about our CVRM expertise. https://bit.ly/4349YYu #CVRM #Cardiovascular #ClinicalTrials
-
-
Now that the traditional approach to dosing is no longer standard for oncology drug development, sponsors are finding ways to reduce unnecessary adverse events. This white paper explores how a holistic view of safety, efficacy, pharmacokinetic and biomarkers can help sponsors build on the dose optimization model encouraged by the FDA. Download now. https://bit.ly/3D15xmv #Oncology #Hematology #Biotech #ClinicalTrials #Diversity
-
-
With 500 oncology clinical trials for biotech customers in the last 5 years, IQVIA Biotech has the oncology expertise you need across cell and gene therapies, biologics and small molecules. Discover how our full-service clinical development solutions can advance your oncology breakthrough. https://bit.ly/435cZHR #Oncology #ClinicalDevelopment #ClinicalResearch #ClinicalTrials
-
-
Cell and gene therapy (CAGT) is following a rapid upwards trajectory, but the best methods for post-trial long-term follow-up (LTFU) are still evolving. With the FDA and EMA issuing guidelines for the design and key data elements of required LTFU studies for CAGT, IQVIA Biotech’s Erin Finot, MS, MBA and IQVIA’s Barbara Isquith Arone, MS consider how best to meet them head-on. Read now. https://bit.ly/4gL3C3e #Biotech #GeneTherapy #CAGT #CellTherapy #ClinicalTrials
-